Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 08 Mar 2023
95% of athletes are diagnosed and treated for non-invasive heart disease, such as heart attacks or seizures, or implantable cardioverter defibrillator (ICD) shock.
Read Full NewsTest your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is on diagnosing parasomnias!
Late-breaking data from the 2026 ACTRIMS Forum showed that bazedoxifene acetate failed to improve remyelination outcomes in midlife women with relapsing MS, despite a favorable safety profile.
A nurse practitioner at the Rocky Mountain MS Clinic discussed emerging therapeutics, evolving management strategies, and unmet needs in multiple sclerosis, specifically in women’s health.
The FDA has granted priority review to Takeda’s new drug application for oveporexton, an orexin receptor 2-selective agonist, for narcolepsy type 1, with a PDUFA date in the third quarter of 2026.
Paul Nghiem highlights several key takeaways from his talk on cutaneous oncology, touching on various advances in skin cancer management.
VALIANT: Verekitug Reduces Average Annual Asthma Flare-Ups in Phase 2 Trial
REZOLVE-AD: Rezpegaldesleukin Improves Symptoms of Atopic Dermatitis
1.
Psychiatric Disorders Are Common in Dementia Patients.
2.
New BiTE Agent for Small Cell Lung Cancer Approved by the FDA.
3.
Next Day Mood Is Affected by Ability to Recover From Work.
4.
Dementia-like protein buildup found in pancreas cells before cancer develops
5.
Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC
1.
A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing
2.
Unleashing the Power of Immune Triads: A Novel Approach to Cancer Immunotherapy
3.
All You Need To Know About Cancer Antigen 27-29: Causes, Symptoms & Treatment
4.
Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell
5.
First-Line Immuno-Hematology Examinations: Essential Diagnostic Tools for Patient Care
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part VIII
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge